• English
  • Korean
  • Chinese
表紙
市場調査レポート - 240574

非アルコール性脂肪性肝炎:世界の治験レビュー

Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H2, 2013

発行 GlobalData
出版日 ページ情報 英文 79 Pages
電子版即納可
価格
非アルコール性脂肪性肝炎:世界の治験レビュー Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H2, 2013
出版日: 2013年12月30日 ページ情報: 英文 79 Pages
概要

当レポートでは、世界の非アルコール性脂肪性肝炎治療薬の臨床試験について調査し、 地域別の臨床試験数データ、試験段階、試験状況、採用テーマおよびスポンサー企業タイプ別の臨床試験データ、 中断(一時中止、廃止、打ち切り)された試験のリストなどを提供しており、概略以下の構成でお届けします。

目次

  • イントロダクション
    • 非アルコール性脂肪性肝炎
    • レポートガイダンス
  • 臨床試験: 地域別
  • 臨床試験: 国別
    • 臨床試験に寄与している主要5ヵ国 − アジア太平洋地域
    • 臨床試験に寄与している主要5ヵ国 − 欧州
    • 臨床試験に寄与している主要国 − 北米
    • 臨床試験に寄与している主要国 − 中東およびアフリカ
    • 臨床試験に寄与している主要国 − 中南米
  • 臨床試験 BRIC 諸国
  • 臨床試験 G7 諸国
  • 臨床試験 G7 諸国 , 治験ステータス別
  • 臨床試験 E7 諸国
  • 臨床試験 E7 諸国 , 治験ステータス別
  • 相別臨床試験
    • 進行中の治験:相別
  • 臨床試験: 治験ステータス別
  • 未完了の治験
  • 期間ごとの被験者数
  • 有力なスポンサー
    • 主な治験参加企業
  • 有望な治療薬比較
  • 臨床試験プロファイル
    • 臨床試験概要: 主要企業
      • Norgine Limited
      • Galmed International Ltd.
      • Pfizer Inc.
      • Raptor Pharmaceuticals Corp.
      • CATALYSIS, S.L.
      • CROLLL GmbH
      • Immuron Limited
      • Zydus Cadila Healthcare Limited
      • NasVax Ltd.
      • Rottapharm SpA
      • Trophos SA
      • Phenex Pharmaceuticals AG
      • アステラス製薬
      • 持田製薬
      • Gilead Sciences, Inc.
    • 臨床試験概要: トップレベルの大学 / 研究機関 / 病院
      • 横浜市立大学
      • The University of Texas Health Science Center at San Antonio
      • Mayo Clinic
      • Tehran University of Medical Sciences
      • University of California, San Diego
      • Monash University
      • University of Illinois
      • University of California, Davis
      • Yale University
      • Brooke Army Medical Center
      • University of Virginia
      • University of Zurich
      • Medical College of Wisconsin
      • Northwestern University
      • University of Colorado
      • Imperial College London
      • University Hospital, Angers
      • University of Michigan
      • Case Western Reserve University
      • Chinese University of Hong Kong
  • 5つの主要な臨床プロファイル

付録

図表一覧


このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

GlobalData's clinical trial report, "Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H2, 2013" provides data on the Non-Alcoholic Steatohepatitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Non-Alcoholic Steatohepatitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Non-Alcoholic Steatohepatitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Non-Alcoholic Steatohepatitis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by BRIC Nations
  • Clinical Trials by G7 Nations
  • Clinical Trials in G7 Nations by Trial Status
  • Clinical Trials by E7 Nations
  • Clinical Trials in E7 Nations by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Unaccomplished Trials of Non-Alcoholic Steatohepatitis
  • Subjects Recruited Over a Period of Time
  • Prominent Sponsors
    • Top Companies Participating in Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials
  • Prominent Drug Comparison
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Raptor Pharmaceuticals Corp.
      • Clinical Trial Overview of Raptor Pharmaceuticals Corp.
      • Phenex Pharmaceuticals AG
      • Clinical Trial Overview of Phenex Pharmaceuticals AG
      • Immuron Limited
      • Clinical Trial Overview of Immuron Limited
      • Gilead Sciences, Inc.
      • Clinical Trial Overview of Gilead Sciences, Inc.
      • LG Corp.
      • Clinical Trial Overview of LG Corp.
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Genfit SA
      • Clinical Trial Overview of Genfit SA
      • Genextra S.p.a.
      • Clinical Trial Overview of Genextra S.p.a.
      • Galmed International Ltd.
      • Clinical Trial Overview of Galmed International Ltd.
      • CATALYSIS, S.L.
      • Clinical Trial Overview of CATALYSIS, S.L.
    • Clinical Trial Overview of Top Institutes / Government
      • The National Institute of Diabetes and Digestive and Kidney Diseases
      • Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases
      • Tehran University of Medical Sciences
      • Clinical Trial Overview of Tehran University of Medical Sciences
      • Yokohama City University
      • Clinical Trial Overview of Yokohama City University
      • University of California, San Diego
      • Clinical Trial Overview of University of California, San Diego
      • Mayo Clinic
      • Clinical Trial Overview of Mayo Clinic
      • U.S. Department of Veterans Affairs
      • Clinical Trial Overview of U.S. Department of Veterans Affairs
      • Hadassah Medical Organization
      • Clinical Trial Overview of Hadassah Medical Organization
      • University of Michigan
      • Clinical Trial Overview of University of Michigan
      • The University of Texas Health Science Center at San Antonio
      • Clinical Trial Overview of The University of Texas Health Science Center at San Antonio
      • Imperial College London
      • Clinical Trial Overview of Imperial College London
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Non-Alcoholic Steatohepatitis Therapeutics Market, Global, Clinical Trials by Zone, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Market, Global, Clinical Trials by Top Countries, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, North America, Top Countries, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, BRIC Countries, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, G7 Countries, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, E7 Countries, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Market, Global, Clinical Trials by Phase, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Market, Global, Clinical Trials by Trial Status, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Market, Global, Withdrawn Clinical Trials, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Market, Global, Terminated Clinical Trials, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Global, Key Sponsors, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Raptor Pharmaceuticals Corp., 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Phenex Pharmaceuticals AG, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Immuron Limited, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by LG Corp., 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Genfit SA, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Genextra S.p.a., 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Galmed International Ltd., 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by CATALYSIS, S.L., 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Yokohama City University, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Health Science Center at San Antonio, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2013*

List of Figures

  • Non-Alcoholic Steatohepatitis Therapeutics Market, Global, Clinical Trials by Zone (%), 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Market, Global, Clinical Trials by Top Countries, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, North America, Top Countries (%), 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, BRIC Countries (%), 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, G7 Countries (%), 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, E7 Countries (%), 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Market, Global, Clinical Trials by Phase (%), 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Market, Global, Clinical Trials by Trial Status, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Global, Key Sponsors, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013*
  • Non-Alcoholic Steatohepatitis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013*
  • GlobalData Methodology
Back to Top